117 related articles for article (PubMed ID: 23498069)
1. [New evidence in the secondary prevention of thromboembolic disease].
Marchena Yglesias PJ
Med Clin (Barc); 2012 Oct; 139 Suppl 2():24-30. PubMed ID: 23498069
[TBL] [Abstract][Full Text] [Related]
2. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
[TBL] [Abstract][Full Text] [Related]
3. [New oral anticoagulants in the treatment of venous thromboembolic disease].
Calvo Romero JM; Lima Rodríguez EM
Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
Welzel D; Hull R; Fareed J
Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
[TBL] [Abstract][Full Text] [Related]
5. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
Páramo JA
Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
[No Abstract] [Full Text] [Related]
6. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS
Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
[TBL] [Abstract][Full Text] [Related]
7. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
8. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants: a review of new agents.
Wanat MA
Postgrad Med; 2013 Jul; 125(4):103-14. PubMed ID: 23933899
[TBL] [Abstract][Full Text] [Related]
10. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
Blanco-Molina A
Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
[TBL] [Abstract][Full Text] [Related]
11. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
13. Treatment of venous thromboembolism with dabigatran.
Schulman S
Curr Opin Pulm Med; 2012 Sep; 18(5):410-5. PubMed ID: 22617811
[TBL] [Abstract][Full Text] [Related]
14. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
15. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
16. A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation.
Sairaku A; Yoshida Y; Ando M; Hirayama H; Nakano Y; Kihara Y
Clin Drug Investig; 2013 Nov; 33(11):847-53. PubMed ID: 24081373
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
18. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
19. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
Douketis J; Bell AD; Eikelboom J; Liew A
Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
[TBL] [Abstract][Full Text] [Related]
20. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
Schaefer JK; McBane RD; Black DF; Williams LN; Moder KG; Wysokinski WE
Thromb Haemost; 2014 Nov; 112(5):947-50. PubMed ID: 25118790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
